GN Audio
GN.CO Large CapHealthcare · Medical Devices
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
GN Audio en bref
GN Audio (GN.CO) is currently trading at 97,70 € with a market capitalization of 12,3 Md €. The trailing P/E ratio stands at 54.28x, with a forward P/E of 17.59x. The 52-week range spans from 85,12 € to 125,90 €; the current price is 22.4% below the yearly high. Year-over-year revenue growth stands at -8.2%.
💰 Dividende
GN Audio currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
12 analystes évaluent GN Audio (GN.CO) au consensus : Acheter. L'objectif de cours moyen est de 114,54 €, soit un potentiel de +17.23% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 80,65 € à 131,80 €.
GN Audio : la thèse d'investissement en détail
GN Audio (GN.CO) operates in the Healthcare — specifically Medical Devices — and is headquartered in Denmark. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Wall Street consensus sits at Buy with an average price target implying roughly 17.23% upside from current levels — analyst sentiment is firmly constructive.
Le scénario baissier
Revenue is contracting at -8.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion.
À surveiller
- The forward P/E of 17.59x is meaningfully below the trailing 54.28x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 54.41% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- –CA en contraction (-8.2% sur un an)
- –Actuellement non rentable
- –Multiple de valorisation élevé (P/E 54.28x)
- –Actuellement jugée surévaluée
- –Free cash flow négatif
Aperçu technique
The price is in a transition zone relative to the moving averages — no clear signal.
Profil de risque
The data points to market-like volatility.
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy GN Audio?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news